Rights and permissions
About this article
Cite this article
Home-based IV therapy least costly option for multiple myeloma. Pharmacoecon. Outcomes News 331, 8 (2001). https://doi.org/10.1007/BF03269597
Published:
Issue Date:
DOI: https://doi.org/10.1007/BF03269597